OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Yale University

6 Projects | 4 Researchers | $753,828 Invested

2010

Yale University

Paul Lombroso, MD

Screening for Inhibitors of STEP

  • Funding Amount: $142,300
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2009

Yale University

Paul Lombroso, MD

Screening for Inhibitors of STEP

  • Funding Amount: $138,600
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2007

Yale University

Paul Lombroso, MD

Screening for Inhibitors of STEP

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2007

Yale University

Anthony Koleske, PhD

Inhibition of Rho signaling to prevent dendritic and synapse loss in Alzheimer’s Disease

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

Yale University

Stephen Strittmater, PhD

Nogo Antagonists in Axon Regeneration and Plasticity

  • Funding Amount: $267,928
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Yale University

Joyce Chase

"Cognition Enhancers, Anti-Alzheimer and Neuroprotective Drugs" Symposium

  • Funding Amount: $5,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed